Adenovirus-mediated transgene expression in nonhuman primate brain

Human Gene Therapy

Volumn 10, Issue 7, 1999, Pages 1175-1184

  Bohn, Martha C ^a,b,h   Choi Lundberg, Derek L ^b,c   Davidson, Beverly L ^d   Leranth, Csaba ^e   Kozlowski, Dorothy A ^a   Smith, Jonathan C ^e,f   Kerry O'Banion, M ^b   Redmond Jr , D Eugene ^e,g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c GENENTECH INC   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g St Kitts Biomedical Research Foundation   (Saint Kitts and Nevis)

^h CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DEXAMETHASONE; HLA DR ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CERCOPITHECIDAE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE TRANSFER; LONG TERMINAL REPEAT; MALE; NERVE CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ROUS SARCOMA ONCOVIRUS; SIMIAN VIRUS 40; SUBSTANTIA NIGRA; TRANSGENE; VIRUS TITRATION;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CAUDATE NUCLEUS; CERCOPITHECUS AETHIOPS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MALE; TIME FACTORS; TRANSGENES;

EID: 0033135782     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018166     Document Type: Article

References (56)

1. AEBISCHER, P., GODDARD, M., SIGNORE, A.P., and TIMPSON, R.L. (1994). Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp. Neurol. 126, 151-158.
2. AKLI, S., CAILLAUD, C. VIGNE, C., STRATFORD-PERRICAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHN, A., and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224-228.
3. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G., and MASTRANGELI, A. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 224-228.
4. BANKIEWICZ, K.S., LEFF, S.E., NAGY, D., JUNGLES, S., ROKOVICH, J., SPRATT, K., COHEN, L., LIBONATI, M., SNYDER, R.O., and MANDEL, R.J. (1997). Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp. Neurol. 144, 147-156.
5. BANKIEWICZ, K.S., BRINGAS, J.R., McLAUGHLIN, W., PIVIROTTO, P., HUNDAL, R., YANG, B., EMBORG, M.E., and NAGY, D. (1998). Application of gene therapy for Parkinson's disease: Nonhuman primate experience. Adv. Pharmacol. 42, 801-806.
6. BAUMGARTNER, B.J., and SHINE, H.D. (1997). Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J. Neurosci. 17, 6504-6511.
7. BETZ, A.L., SHAKUI, P., and DAVIDSON, B.L. (1998). Gene transfer to rodent brain with recombinant adenoviral vectors: Effects of infusion parameters, infectious titer, and virus concentration on transduction volume. Exp. Neurol. 150, 136-142.
8. BLESCH, A., and TUSZYNSKI, M. (1996). Ex vivo gene therapy for Alzheimer's disease and spinal cord injury. Clin. Neurosci. 3, 268-274.
9. BOHN, M.C., and CHOI-LUNDBERG, D.L. (1998). Neurotrophic factor gene therapy for neurodegenerative diseases. In Gene Therapy. T. Boulikas, ed. (Gene Therapy Press, Palo Alto, CA) pp. 265-277.
10. BRODY, S.L., and CRYSTAL, R.G. (1994). Adenovirus-mediated in vivo gene transfer. Ann. N.Y. Acad. Sci. 716, 90-101. [Review]
11. BYRNES, A.P., RUSBY, J.E., WOOD, M.J.A., and CHARLTON, H.M. (1995). Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66, 1015-1024.
12. CEPKO, C. (1989). Lineage analysis and immortalization of neural cells via retrovirus vectors. In Molecular Neurobiological Techniques, Neuromethods. A.A. Boulton, G.B. Baker, and A.T. Campagnoni, eds. (Humana Press, Clifton, NJ) pp. 177-219.
13. CHEN, S.-H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 3054-3057.
14. CHOI-LUNDBERG, D.L. (1997). An Adenoviral Vector Encoding Glial Cell Line-Derived Neurotrophic Factor (GDNF) Protects Rat Dopaminergic Neurons from Degeneration. Ph.D. thesis. (University of Rochester, Rochester, NY).
15. CHOI-LUNDBERG, D.L., and BOHN, M.C. (1998). Applications of gene therapy to neurological diseases and injuries. In Stem Cell Biology and Gene Therapy. P.J. Quesenberry, G.S. Stein, B. Forget, and S. Weissman, eds. (John Wiley & Sons, New York) pp. 503-553.
16. CHOI-LUNDBERG, D.L., LIN, Q., CHANG, Y.-N., CHIANG, Y.L., HAY, C.M., MOHAJERI, H., DAVIDSON, B.L., and BOHN, M.C. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841.
17. CHOI-LUNDBERG, D.L., LIN, Q., SCHALLERT, T., CRIPPENS, D., DAVIDSON, B.L., CHANG, Y.-N., CHIANG, Y.L., QIAN, J., BARDWAJ, L., and BOHN, M.C. (1998). Behavioral and cellular protection of rat dopaminergic neurons elicited by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154, 261-275.
18. COLAK, A., GOODMAN, J.C., CHEN, S.-H., WOO, S.L.C., GROSSMAN, R.G., and SHINE, H.D. (1995). Adenovirus-mediated gene therapy for experimental spinal cord tumors: Tumoricidal efficacy and functional outcome. Brain Res. 691, 76-82.
19. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
20. DAVIDSON, B.L., and BOHN, M.C. (1997). Recombinant adenovirus. A gene transfer vector for study and treatment of CNS diseases. Exp. Neurol. 144, 125-130.
21. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
22. DAVIDSON, B.L., DORAN, S.E., SHEWACH, D.S., LATTA, J.M., HARTMAN, J.W., and ROESSLER, B.J. (1994). Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatto following adenoviral mediated gene transfer. Exp. Neurol. 125, 258-267.
23. DORAN, S., ROESSLER, B., HARTMAN, J., HOFF, J., SHEWACH, D., and DAVIDSON, B. (1994). Adenovirus-mediated in vivo gene transfer into the central nervous system of a nonhuman primate. Clin. Neurosurg. 41, 242-257.
24. DURBEC, P., MARCOS-GUTIERREZ, C.V., KILKENNY, C., GRIGORIOU, M., WARTIOWAARA, K., SUVANTO, P., SMITH, D., PONDER, B., COSTANTINI, F., SAARMA, M., SARIOLA, H., and PACHNIS, V. (1996). GDNF signalling through the ret receptor tyrosine kinase. Nature (London) 381, 789-793.
25. DURING, M.J., NAEGELE, J.R., O'MALLEY, K.L., and GELLER, A.I. (1994). Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
26. DURING, M.J., SAMULSKI, R.J., ELSWORTH, J.D., KAPLITT, M.G., LEONE, P., XIAO, X., LI, J., FREESE, A., TAYLOR, J.R., ROTH, R.H., SLADEK, J.R., O'MALLEY, K.L., and REDMOND, D.E., JR. (1998). In vivo expression of therapeutic human genes for dopamine production in the caudales of MPTP-treated monkeys using an AAV vector. Gene Ther. 5, 820-827.
27. EMERICH, D.F., WINN, S.R., HARPER, J., HAMMANG, J.P., BAETGE, E.E., and KORDOWER, J.H. (1994). Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 349, 148-164.
28. EMERICH, D., WINN, S., HANTRAYE, P., PESCHANSKI, M., CHEN, E., CHU, Y., McDERMOTT, P., BAETGE, E., and KORDOWER, J. (1997). Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature (London) 386, 395-399.
29. GHADGE, G.D., ROOS, R.P., KANG, U.J., WOLLMANN, R., FISHMAN, P.S., KALYNYCH, A.M., BARR, E., and LEIDEN, J.M. (1995). CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2, 132-137.
30. GINSBERG, H. (1996). The ups and downs of adenovirus vectors. Bull. N.Y. Acad. Med. 73, 53-58.
31. GINSBERG, H.S., LUNDHOLM-BEAUCHAMP, U., HORSWOOD, R.L., PERNIS, B., CHANOCK, R.M., and PRINCE, G.A. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. U.S.A. 86, 3823-3827.
32. GOODMAN, J.C., TRASK, T.W., CHEN, S.-H., WOO, S.L.C., GROSSMAN, R.G., CAREY, K.D., HUBBARD, G.B., CARRIER, D.A., RAJAGOPALAN, S., AGULIAR-CORDOVA, E., and SHINE, H.D. (1996). Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic and molecular studies. Hum. Gene Ther. 7, 1241-1250.
33. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
34. INSTITUTE OF LABORATORY ANIMAL RESOURCES. (1996). Guide for the Care and Use of Laboratory Animals, 7th Ed. (National Academy Press, Washington, D.C.) p. 125.
35. JIN, B.K., BELLONI, M., CONTI, B., FEDEROFF, H.J., STARR, R., SON, H., BAKER, H., and JOH, T.H. (1997). Long-term in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum. Gene Ther. 7, 2015-2027.
36. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
37. KLEIN, R.L., MEYER, E.M., PEEL, A.L., ZOLOTUKHIN, S., MEYERS, C., MUZYCZKA, N., and KING, M.A. (1998). Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150, 183-194.
38. KORDOWER, J., MUFSON, E., GRANHOLM, A., HOFFER, B., and FRIDEN, P. (1993). Delivery of trophic factors to the primate brain. Exp. Neurol. 124, 21-30. [Review]
39. KORDOWER, J.H., WINN, S.R., LIU, Y.T., MUFSON, E.J., SLADEK, J.R., JR., HAMMANG, J.P., BAETGE, E.E., and EMERICH, D.F. (1994). The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 91, 10898-10892.
40. KRAMM, C.M., SENAESTEVERS, M., BARNETT, F.H., RAINOV, N.G., SCHUBACK, D.E., YU, J.S., PECHAN, P.A., PAULUS, W., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1995). Gene therapy for brain tumors. Brain Pathol. 5, 345-381. [Review]
41. LAWRENCE, M.S., FOELLMER, H., ELSWORTH, J.D., KIM, Y., LERANTH, C., KOZLOWSKI, D.A., FOLSOM, A., DAVIDSON, B.L., BOHN, M.C., and REDMOND, D.E., JR. (1999). Assessment of inflammatory responses and impact on LacZ transgene expression following adenoviral vector delivery to the primate caudate nucleus. Gene Therapy. In press.
42. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
43. LINDSAY, R.M. (1994). Neurotrophic growth factors and neurodegenerative diseases: Therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol. Aging 15, 249-251.
44. NILAVER, G., MULDOON, L.L., KROLL, R.A., PAGEL, M.A., BREAKEFIELD, X.O., DAVIDSON, B.L., and NEUWELT, E.A. (1995). Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc. Natl. Acad. Sci. U.S.A. 92, 9829-9833.
45. OLDFIELD, E.H., RAM, Z., CULVER, K.W., BLAESE, R.M., DEVROOM, H.L., and ANDERSON, W.F. (1993). Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-69.
46. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDEL, J.-L. (1992). Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 2581-2584.
47. SCHNEIDER, D.B., FLY, C.A., DICHEK, D.A., and GEARY, R.L. (1998). Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. Hum. Gene Ther. 9, 815-821.
48. STYREN, S.D., CIVIN, W.H., and ROGERS, J. (1990). Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp. Neurol. 110, 93-104.
49. SULLIVAN, D.E., DASH, S., DU, H., HIRAMATSU, N., AYDIN, F., KOLLS, J., BLANCHARD, J., BASKIN, G., and GERBER, M.A. (1997). Liver-directed gene transfer in non-human primates. Hum. Gene Ther. 8, 1195-1206.
50. TREANOR, J.J.S., GOODMAN, L., DE SAUVAGE, F., STONE, D.M., POULSEN, K.T., BECK, C.D., GRAY, C., ARMANINI, M.P., POLLOCK, R.A., HEFTI, F., PHILLIPS, H.S., GODDARD, A., MOORE, M.W., BUJ-BELLO, A., DAVIES, A.M., ASAI, N., TAKAHASKI, M., VANDLEN, R., HENDERSON, C.E., and ROSENTHAL, A. (1996). Characterization of a multicomponent receptor for GDNF. Nature (London) 382, 80-83.
51. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
52. TRUPP, M., ARENAS, E., FAINZILBER, M., NILSSON, A.-S., SIEBER, B.-A., GRIGORIOU, M., KILKENNY, C., SALAZAR-GRUESO, E., PACHNIS, V., ARUMAE, U., SARIOLA, H., SAARMA, M., and IBANEZ, C.F. (1996). Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature (London) 381, 785-789.
53. TUSZYNSKI, M., ROBERTS, J., SENUT, M., U, H.S., and GAGE, F. (1996). Gene therapy in the adult primate brain: Intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 3, 305-314.
54. VERMA, I.M., and SOMIA, N. (1997). Gene therapy - promises, problems and prospects. Nature (London) 237, 239-242.
55. WILMOTT, R., AMIN, R., PEREZ, C., WERT, S., KELLER, G., BOIVIN, G., HIRSCH, R., DE INOCENCIO, J., LU, P., REISING, S., YEI, S., WHITSETT, J., and TRAPNELL, B. (1996). Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum. Gene Ther. 7, 301-318.
56. WOOD, M., CHARLTON, H., WOOD, K., KAJIWARA, K., and BYRNES, A. (1996). Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19, 497-501.